T. Mihaescu (Iasi, Romania), E. Kunter (Istanbul, Turkey)
Multidrug-resistant tuberculosis in a tuberculosis unit – results of five years
P. Mota, N. Diogo, J. Pina (Lisbon, Portugal)
|  |
A joint TB re-treatment project for the poor
H. Danusantoso, Yulismar, G. T. The (Jakarta, Indonesia; Almere, Netherlands)
| |
Knowledge and management of tuberculosis among general practitioners in a high burden developing country
I. Muhammad, J. A. Khan, S. Romana, Z. Tatheer (Karachi, Pakistan)
| |
Analysis of treatment failure in cohort I of the Tomsk DOTS-plus program (2000–2002)
T. P. Tonkel, G. G. Peremitin, O. B. Sirotkina, A. K. Strelis, A. D. Pasechnikov, A. B. Yedilbayev, A. A. Golubkov, Y. G. Andreev (Tomsk, Russian Federation; Boston, United States Of America)
| |
Late consequences of bronchial tuberculosis – a review of 81 cases
M. Alexe, R. Ulmeanu, E. Crisan, P. Grigore, I. Andreescu (Bucharest, Romania)
| |
Long-term results of drug resistant tuberculosis treatment
J. Beli, J. Bushati (Tirana, Albania)
| |
The diagnostic meaning of clinical-epidemiological signs among MDR TB patients
M. D. Safaryan, D. G. Khachatryan (Yerevan, Armenia)
| |
Multi-drug resistant tuberculosis (MDR-TB) in Ramnicul Valcear, Romania; drug treatment, resistance testing and adverse drug reactions
S. White, J. S. Mann (Wolverhampton, United Kingdom)
| |
Pattern of drug resistance among patients who fail Cat II regimen and patients who fail standard treatment: is there any difference?
P. Tabarsi, M. Mirsaeidi, A. Nooraki, M. Amiri, M. Kazempour, D. Mansouri, M. R. Masjedi, A. A. Velayati (Tehran, Islamic Republic Of Iran)
| |
Main indicator evolution of the tuberculosis endemic after 5 years since DOTS was established in a pilot sector of Bucharest
C. I. Didilescu, E. Ibraim, D. I. Chiotan, D. Lugoji, R. Spataru, M. Popescu, T. Palaghianu, I. Dediu, C. Teoibas (Bucharest, Romania)
| |
Efficacy of standard 1st category regimen of chemotherapy in patients with smear positive destructive pulmonary tuberculosis in Chernovetskaya Oblast, Ukraine
S. A. Cherenko, A. V. Boyko (Kiev, Chernovtsy, Ukraine)
| |
Diagnostic of sensitivity mycobacterium tuberculosis strains to isoniazid and rifampicin by simultaneous identification of mutations in rpoB, katG, inhA and ahpC-oxyR genes with biological microchips
K. Y. Galkina, E. Y. Nosova, O. I. Scotnicova, A. M. Moroz (Moscow, Russian Federation)
| |
Present aspects of teenager‘s tuberculosis (14–18 years) in the 4th sector of Bucharest, Romania
R. D. Spataru, N. C. Didilescu (Bucharest, Romania)
| |
Our experience with multiple drug-resistant tuberculosis in Plovdiv Region, Bulgaria – 1999–2004
V. G. Davchev, A. A. Torossian, E. N. Bachiiska, I. I. Gaidarova, M. G. Dimitrova (Plovdiv, Bulgaria)
| |
Pattern of presentation of tuberculosis and the hospital prevalence of tuberculosis and human immunodeficiency virus co-infection in University College Hospital, Ibadan: a review of five years (1998–2002)
O. M. Ige, O. M. Sogaolu, O. A. Ogunlade (Ibadan, Nigeria)
| |
Analysis of mutations in multiple-drug-resistant M. tuberculosis strains isolated in Kyrgyzstan
J. T. Isakova, E. U. Usupova, Z. A. Goncharova, A. F. Tumashova, J. K. Kojomkulov, M. J. Kojomkulov, T. C. Chubakov, A. S. Alisherov, A. A. Aldashev (Bishkek, Kyrgyzstan)
| |
The impact of first symptoms on patient delay in pulmonary tuberculosis
L. Pehme, K. Rahu, M. Rahu, A. Altraja (Tartu, Tallinn, Tartu-Tallinn, Estonia)
| |
Epidemiologic trends in children with tuberculosis (2001–2005)
N. Pavlov, S. Dragisic-Ivulic, V. Pavlov (Split, Croatia)
| |
Factors associated with changing diagnosis of tuberculosis in Taipei
C. Y. Chiang, K. T. Luh, D. A. Enarson, T. P. Lin, Y. C. Wu, C. Y. Lu (Paris, France; Taipei, Taiwan, Province Of China)
| |
Effect of fluoroquinolones on microbiologic outcome and survival in the treatment of multidrug-resistant tuberculosis
T. Törün, K. Tahaoglu, I. Özmen, G. K. Güngör, T. Sevim, G. Ataç, E. Aksoy, G. Gündüz (Istanbul, Turkey)
| |